How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.com68Ga-labeled NY108 PET Imaging in Patients
Description:
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY108 (89Zr-NY108) PET Imaging in patients with Prostate cancer.
Government Study Link:
NCT05623878 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience